| 前收市價 | 76.43 |
| 開市 | 78.13 |
| 買盤 | 75.30 x 500 |
| 賣出價 | 75.99 x 500 |
| 今日波幅 | 73.41 - 78.13 |
| 52 週波幅 | 8.28 - 99.41 |
| 成交量 | |
| 平均成交量 | 6,582,842 |
| 市值 | 8.346B |
| Beta 值 (5 年，每月) | 1.10 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.92 |
| 業績公佈日 | 2024年7月24日 - 2024年7月29日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 113.80 |
Motley FoolIs Viking Therapeutics Incredibly Undervalued?
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
Motley FoolCan This High-Flying Stock 10x in 10 Years?
This midcap biotech could see huge success ahead -- or disappointment.
Insider MonkeyViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
